March 9, 2020 / 10:33 AM / a month ago

BRIEF-Ascentage Pharma Group International Says Co Received Nod In U.S & China For Phase Ib/Ii Clinical Trials Of APG-2575

March 9 (Reuters) - Ascentage Pharma Group International :

* RECEIVED APPROVALS IN U.S AND CHINA FOR PHASE IB/II CLINICAL TRIALS OF APG-2575 DEVELOPED BY CO Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below